Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study

Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer

(2018) Kathryn C. Arbour et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review

(2016) Pramod Kumar et al.   CURRENT PHARMACEUTICAL DESIGN

A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET Platform

(2013) A.-J. M. de Graan et al.   CLINICAL CANCER RESEARCH

Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer

(2011) Masashi Ando et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel

(2008) E. R. Gardner et al.   CLINICAL CANCER RESEARCH

Recent Developments in Taxane Drug Delivery

(2008) Ahmad Safavy   Current Drug Delivery